OMOP Concept 35896649
20 ML atezolizumab 60 MG/ML Injectable Solution [Tecentriq] by Originalis B.V.
StandardDrugRxNorm ExtensionOMOP5040884Marketed Product
Maps from
1
Descendants
0
Valid from
1 Feb 2021
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
1 source code normalizes to 20 ML atezolizumab 60 MG/ML Injectable Solution [Tecentriq] by Originalis B.V. via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| dm+d | 39255211000001109 | Tecentriq 1200mg/20ml concentrate for solution for infusion vials | Non-standard |
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(20)Roll up to these when you need a wider cohort.
- 120 ML atezolizumab 60 MG/ML Injectable Solution
- 120 ML atezolizumab 60 MG/ML Injectable Solution [Tecentriq]
- 1atezolizumab 60 MG/ML Injectable Solution
- 1atezolizumab 60 MG/ML Injectable Solution [Tecentriq]
- 2atezolizumab 60 MG/ML
- 2atezolizumab 60 MG/ML [Tecentriq]
- 2atezolizumab Injectable Solution
- 2atezolizumab Injectable Solution [Tecentriq]
- 3atezolizumab
- 3atezolizumab; parenteral
- 4Anti-PD-L1 antibody
- 4PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
- 4T-cell activator
- 5Immunostimulatory monoclonal antibody
- 5Immunotherapeutic
- 5MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
- 6Antibody medication
- 6ANTINEOPLASTIC AGENTS
- 6Antineoplastics by class effect
- 7ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Get this concept via the API
Resolve 20 ML atezolizumab 60 MG/ML Injectable Solution [Tecentriq] by Originalis B.V. - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/35896649?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card